MeSH D006470 - hemorrhage
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010335:Pathologic processes
0 Companies
0 Drugs
Success rate
D006470:
Hemorrhage
D004438:Ecchymosis
0 Companies
0 Drugs
Success rate
D004844:Epistaxis
0 Companies
0 Drugs
Success rate
D005130:Eye hemorrhage
0 Companies
0 Drugs
Success rate
D006395:Hemarthrosis
0 Companies
0 Drugs
Success rate
D006398:Hematocele
0 Companies
0 Drugs
Success rate
D006406:Hematoma
0 Companies
0 Drugs
Success rate
D006417:Hematuria
0 Companies
0 Drugs
Success rate
D006431:Hemobilia
0 Companies
0 Drugs
Success rate
D006465:Hemoperitoneum
0 Companies
0 Drugs
Success rate
D006469:Hemoptysis
0 Companies
0 Drugs
Success rate
D006471:Gastrointestinal hemorrhage
D006472:Oral hemorrhage
0 Companies
0 Drugs
Success rate
D006491:Hemothorax
0 Companies
0 Drugs
Success rate
D011693:Purpura
D012771:Hemorrhagic shock
D014592:Uterine hemorrhage
D016063:Surgical blood loss
0 Companies
0 Drugs
Success rate
D019106:Postoperative hemorrhage
0 Companies
0 Drugs
Success rate
D019315:Retrobulbar hemorrhage
0 Companies
0 Drugs
Success rate
D020300:Intracranial hemorrhages
0 Companies
0 Drugs
Success rate
D058734:Exsanguination
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Novast Laboratories | Desmopressin | Desmopressin | 2019-06-06 | |||
| Glenmark Pharmaceuticals | Desmopressin | Desmopressin | 2015-05-28 | |||
| NATCO Pharma | Desmopressin | Desmopressin | 2014-06-27 | |||
| Boehringer Ingelheim | Idarucizumab | Praxbind | 2015-11-20 | |||
| AstraZeneca | Andexanet alfa | Ondexxya | 2019-04-26 | |||
| Bausch Health Companies | Desmopressin | Desmopressin | 1999-01-25 | |||
| Bayer | Aprotinin | Trasylol | 1993-12-29 |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
94%15/16
Phase 2
73%16/22
Phase 3
62%33/53
Approved: 10Overall Success rate: 42%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use